Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
The 22-year-old launched his disgusting attack at North Manchester General Hospital on October 1 last year.
Merseyside Police has confirmed that detectives are investigating a report of a firearm discharge in Speke last night.
Former footballer cleared of sexually taking advantage of a 14-year-old girl.